IP Verse

Fluid Delivery Device With Transcutaneous Access Tool, Insertion Mechanism And Blood Glucose Monitoring For Use Therewith

Patent No. EP4201327 (titled "Fluid Delivery Device With Transcutaneous Access Tool, Insertion Mechanism And Blood Glucose Monitoring For Use Therewith") was filed by Insulet on Mar 29, 2013. The application was issued on Jun 19, 2024.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_COA_0000034/2026Feb 20, 2026EoflowAppeal
UPC_COA_0000930/2025Dec 19, 2025EoflowAppeal
UPC_CFI_0001167/2025Oct 14, 2025InsuletGeneric
UPC_CFI_774/2025Aug 21, 2025InsuletGeneric
UPC_CFI_773/2025Aug 21, 2025InsuletGeneric
UPC_CFI_477/2025May 28, 2025InsuletGeneric
APP_67784/2024Dec 23, 2024A Menarini DiagnosticsGeneric
APP_65673/2024Dec 12, 2024EoflowGeneric
UPC_CFI_793/2024Dec 11, 2024InsuletInfringement
UPC_CFI_787/2024Dec 10, 2024InsuletCounter Claim For Infringement

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KELLER SCHNEIDER PATENTANWALTSMar 19, 2025-
INSPICOS PSMar 19, 2025INSPICOS PS
EOFLOWMar 18, 2025HOYNG ROKH MONEGIER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4201327

INSULET
Application Number
EP23152851A
Filing Date
Mar 29, 2013
Status
Granted And Under Opposition
May 17, 2024
Publication Date
Jun 19, 2024
External Links
Slate, Register , Google Patents